1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CORCEPT THERAPEUTICS INC
Corcept Therapeutics Inc XNAS: CORT
41.30 4.99 (13.74%)
5.9M

XNAS 22 Jan, 2026 4:15 PM (EST)

Watchlist

Portfolio

Alert

Positive Trial
Corcept rises on Thursday after late-stage trial shows its drug cuts death risk from ovarian cancer See details

Corcept Therapeutics Inc RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Corcept Therapeutics Inc technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis